← Leaderboards
Joseph A. Vita
Boston University Medical Campus
$19,118,512
Attributed
$19,118,512
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.3M · FY2005–13$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$35,735,541 · 14
By mechanism
P50$15,642,444 · 4
P01$10,487,081 · 4
R01$6,784,646 · 4
K12$2,790,883 · 1
M01$30,487 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Tory M Hagen$5,436,883
- Daniel J Gottlieb$5,199,553
- Carl S Apstein$2,872,088
- Wilson S. Colucci$9,273,896
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideAtherosclerosisBlood VesselsOxidative StressHuman SubjectFunctional DisorderMitochondriaClinical ResearchVascular DiseasesInsightResearch PersonnelProgramsUniversitiesAccountingResponseSignal TransductionPhenotypeAntioxidantsEndothelial CellsCardiovascular DiseasesProductionReactive Oxygen SpeciesResearch DesignAscorbate
Grant awards (46)
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity$555,300
R01 · FY2013 · HL · contact PI
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM$530,350
P01 · FY2013 · HL · contact PI
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM$560,327
P01 · FY2012 · HL · contact PI
Boston University Medical Center Leadership Program in Vascular Medicine$427,083
K12 · FY2012 · HL · contact PI
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM$588,284
P01 · FY2011 · HL · contact PI
Vascular Consequences of Insulin Resistance and Obesity$2,351,521
P50 · FY2010 · HL · contact PI
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance$779,869
P50 · FY2010 · HL · contact PI
Vascular Consequences of Insulin Resistance and Obesity$2,288,213
P50 · FY2009 · HL · contact PI
Boston University Medical Center Leadership Program in Vascular Medicine$1,175,505
K12 · FY2009 · HL · contact PI
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance$759,822
P50 · FY2009 · HL · contact PI
Mitochondrial Metabolism and Endothelial Dysfunction$559,800
P01 · FY2009 · HL · contact PI
Determinants of Shear Stress-Mediated Arterial Remodeling$497,985
R01 · FY2009 · HL · contact PI
Vascular Consequences of Insulin Resistance and Obesity$2,180,011
P50 · FY2008 · HL · contact PI
Boston University Medical Center Leadership Program in Vascular Medicine$810,328
K12 · FY2008 · HL · contact PI
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance$725,619
P50 · FY2008 · HL · contact PI
Mitochondrial Metabolism and Endothelial Dysfunction$532,923
P01 · FY2008 · HL · contact PI
Determinants of Shear Stress-Mediated Arterial Remodeling$477,436
R01 · FY2008 · HL · contact PI
Vascular Consequences of Insulin Resistance and Obesity$2,162,301
P50 · FY2007 · HL · contact PI
Clinical Utility of Endothelial Function in PAD$947,951
R01 · FY2007 · HL · contact PI
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance$721,577
P50 · FY2007 · HL · contact PI
Mitochondrial Metabolism and Endothelial Dysfunction$517,155
P01 · FY2007 · HL · contact PI
Determinants of Shear Stress-Mediated Arterial Remodeling$476,686
R01 · FY2007 · HL · contact PI
Boston University Medical Center Leadership Program in Vascular Medicine$377,967
K12 · FY2007 · HL · contact PI
Vascular Consequences of Insulin Resistance and Obesity$2,185,318
P50 · FY2006 · HL · contact PI
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance$670,898
P50 · FY2006 · HL · contact PI
Mitochondrial Metabolism and Endothelial Dysfunction$480,122
P01 · FY2006 · HL · contact PI
Determinants of Shear Stress-Mediated Arterial Remodeling$478,012
R01 · FY2006 · HL · contact PI
Administrative Core$157,367
P50 · FY2006 · HL · contact PI
Clinical Utility of Endothelial Function in PAD$999,588
R01 · FY2005 · HL
Mitochondrial Metabolism and Endothelial Dysfunction$481,723
P01 · FY2005 · HL
VITAMIN C AND GSH: ROLES IN VASCULAR FUNCTION$1,141,942
P01 · FY2004 · HL
Clinical Utility of Endothelial Function in PAD$999,661
R01 · FY2004 · HL
VITAMIN C AND GSH: ROLES IN VASCULAR FUNCTION$1,113,544
P01 · FY2003 · HL
Clinical Utility of Endothelial Function in PAD$999,902
R01 · FY2003 · HL
VITAMIN C AND GSH: ROLES IN VASCULAR FUNCTION$1,085,980
P01 · FY2002 · HL
Vitamin C, glutathione and NO action in humans$262,244
P01 · FY2002 · HL
G6PD DEFIECIENCY AND NO ACTION IN BLACK PATIENTS$219,976
P50 · FY2002 · HL
VITAMIN C AND GSH: ROLES IN VASCULAR FUNCTION$1,059,217
P01 · FY2001 · HL
Vitamin C, glutathione and NO action in humans$262,244
P01 · FY2001 · HL
G6PD DEFIECIENCY AND NO ACTION IN BLACK PATIENTS$219,976
P50 · FY2001 · HL
SALT SENSITIVITY &ENDOTHELIAL FUNCTION$0
M01 · FY2001 · RR
VITAMIN C AND GSH: ROLES IN VASCULAR FUNCTION$1,048,982
P01 · FY2000 · HL
ANTIOXIDANT EFFECTS OF ESTROGEN ON CORONARY REACTIVITY$352,125
R01 · FY2000 · HL
Vitamin C, glutathione and NO action in humans$262,244
P01 · FY2000 · HL
G6PD DEFIECIENCY AND NO ACTION IN BLACK PATIENTS$219,976
P50 · FY2000 · HL
SALT SENSITIVITY &ENDOTHELIAL FUNCTION$30,487
M01 · FY2000 · RR